Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1412254-20-6

Post Buying Request

1412254-20-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1412254-20-6 Usage

General Description

The chemical 1-[(benzyloxy)carbonyl]-3-methylpyrrolidine-3-carboxylic acid is a compound with the molecular formula C18H21NO5. It is a derivative of pyrrolidine and contains a benzyloxy and carbonyl functional group. 1-[(Benzyloxy)carbonyl]-3-methylpyrrolidine-3-carboxylic acid has potential applications in pharmaceuticals and organic synthesis due to its ability to interact with biological systems. Its specific properties and potential uses would require further investigation and study.

Check Digit Verification of cas no

The CAS Registry Mumber 1412254-20-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,1,2,2,5 and 4 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1412254-20:
(9*1)+(8*4)+(7*1)+(6*2)+(5*2)+(4*5)+(3*4)+(2*2)+(1*0)=106
106 % 10 = 6
So 1412254-20-6 is a valid CAS Registry Number.

1412254-20-6Relevant articles and documents

HETEROCYCLIC SPIRO-COMPOUNDS AS AM2 RECEPTOR INHIBITORS

-

, (2020/06/05)

Disclosed are compounds of the formula (I) and pharmaceutically acceptable salts thereof: wherein R1, R2, R4, R5, R6, R7, R8, R9, R10,Z, X1, X2, X3, L2, HET, n and q are as defined herein. The compounds are inhibitors of adrenomedullin receptor subtype 2 (AM2). Also disclosed are the compounds for use in the treatment of diseases modulated AM2, including proliferative diseases such as cancer; pharmaceutical compositions comprising the compounds; methods for preparing the compounds; and intermediates useful in the preparation of the compounds.

PYRROLOPYRIDINES AS KINASE INHIBITORS

-

, (2009/12/23)

Compounds of Formula (I) are useful for inhibition of CHKl and/or CHK2. Methods of using compounds of Formula (I) and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1412254-20-6